Memory T Cells pp 145-154 | Cite as

Memory T-Cell Subsets in Parasitic Infections

  • Sara Colpitts
  • Phillip Scott
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 684)


Parasitic infections remain a major health problem throughout the world and unlike many viral or bacterial diseases, there are no vaccines to help control parasitic diseases. While several important advances have been made that will contribute to the development of parasite vaccines, such as cloning of dominant parasite antigens and a better understanding of the effector T-cell subsets needed for immunity, fundamental questions remain about how to induce long-term immunologic memory in vaccines. Here we examine a few of the experimental models that have been used to elucidate the nature of the memory T cells that are generated during parasitic infections. Although significant hurdles remain in the development of parasite vaccines, studies with both protozoa and gastrointestinal nematodes suggest that long-term immunity induced by vaccination is a realistic goal for control of parasitic infections.


Parasitic Infection Cutaneous Leishmaniasis Central Memory Malaria Vaccine Merozoite Surface Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bloom B, Lambert P-H. The Vaccine Book. New York: Academic Press, 2003.Google Scholar
  2. 2.
    Sallusto F, Lenig D, Forster R et al. Two subsets of memory T-lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401(6754):708–712.CrossRefPubMedGoogle Scholar
  3. 3.
    Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T-cell subsets: function, generation and maintenance. Annu Rev Immunol 2004; 22:745–763.CrossRefPubMedGoogle Scholar
  4. 4.
    Intlekofer AM, Wherry EJ, Reiner SL. Not-so-great expectations: re-assessing the essence of T-cell memory. Immunol Rev 2006; 211:203–213.CrossRefPubMedGoogle Scholar
  5. 5.
    Kaech SM, Wherry EJ. Heterogeneity and cell-fate decisions in effector and memory CD8+ T-cell differentiation during viral infection. Immunity 2007; 27(3):393–405.CrossRefPubMedGoogle Scholar
  6. 6.
    Chang JT, Palanivel VR, Kinjyo I et al. Asymmetric T-lymphocyte division in the initiation of adaptive immune responses. Science 2007; 315(5819):1687–1691.CrossRefPubMedGoogle Scholar
  7. 7.
    Nussenzweig RS, Vanderberg J, Most H et al. Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. Nature 1967; 216(5111):160–162.CrossRefPubMedGoogle Scholar
  8. 8.
    Nussenzweig V, Nussenzweig RS. Rationale for the development of an engineered sporozoite malaria vaccine. Adv Immunol 1989; 45:283–334.CrossRefPubMedGoogle Scholar
  9. 9.
    Mosmann TR, Cherwinski H, Bond MW et al. Coffman RL. Two types of murine helper T-cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136(7):2348–2357.PubMedGoogle Scholar
  10. 10.
    Scott P, Natovitz P, Coffman RL et al. Immunoregulation of cutaneous leishmaniasis. T-cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med 1988; 168(5):1675–1684.CrossRefPubMedGoogle Scholar
  11. 11.
    Heinzel FP, Sadick MD, Holaday BJ et al. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T-cell subsets. J Exp Med 1989; 169(1):59–72.CrossRefPubMedGoogle Scholar
  12. 12.
    Locksley RM, Scott P. Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function. Immunol Today 1991; 12(3):A58–61.CrossRefPubMedGoogle Scholar
  13. 13.
    Janeway CA Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989; 54 Pt 1:1–13.PubMedGoogle Scholar
  14. 14.
    Afonso LC, Scharton TM, Vieira Q et al. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 1994; 263(5144):235–237.CrossRefPubMedGoogle Scholar
  15. 15.
    Gurunathan S, Prussin C, Sacks DL et al. Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. Nat Med 1998; 4(12):1409–1415.CrossRefPubMedGoogle Scholar
  16. 16.
    Gicheru MM, Olobo JO, Anjili CO et al. Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection. Infect Immun 2001; 69(1):245–251.CrossRefPubMedGoogle Scholar
  17. 17.
    Zinkernagel RM, Hengartner H. Protective ‘immunity’ by pre-existent neutralizing antibody titers and preactivated T-cells but not by so-called ‘immunological memory’. Immunol Rev 2006; 211:310–319.CrossRefPubMedGoogle Scholar
  18. 18.
    Zinkernagel RM. On differences between immunity and immunological memory. Curr Opin Immunol 2002; 14(4):523–536.CrossRefPubMedGoogle Scholar
  19. 19.
    Cockburn IA, Zavala F. T-cell memory in malaria. Curr Opin Immunol 2007; 19(4):424–429.CrossRefPubMedGoogle Scholar
  20. 20.
    Reyes-Sandoval A, Harty JT, Todryk SM. Viral vector vaccines make memory T-cells against malaria. Immunology 2007; 121(2):158–165.CrossRefPubMedGoogle Scholar
  21. 21.
    Hayes KS, Bancroft AJ, Grencis RK. Immune-mediated regulation of chronic intestinal nematode infection. Immunol Rev 2004; 201:75–88.CrossRefPubMedGoogle Scholar
  22. 22.
    Belkaid Y, Piccirillo CA, Mendez S et al. CD4+CD25+ regulatory T-cells control Leishmania major persistence and immunity. Nature 2002; 420(6915):502–507.CrossRefPubMedGoogle Scholar
  23. 23.
    Uzonna JE, Wei G, Yurkowski D et al. Immune elimination of Leishmania major in mice: implications for immune memory, vaccination and reactivation disease. J Immunol 2001; 167(12):6967–6974.PubMedGoogle Scholar
  24. 24.
    Sacks D, Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2002; 2(11):845–858.CrossRefPubMedGoogle Scholar
  25. 25.
    Mattner F, Magram J, Ferrante J et al. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol 1996; 26(7):1553–1559.CrossRefPubMedGoogle Scholar
  26. 26.
    Park AY, Hondowicz BD, Scott P. IL-12 is required to maintain a Th1 response during Leishmania major infection. J Immunol 2000; 165(2):896–902.PubMedGoogle Scholar
  27. 27.
    Kane MM, Mosser DM. The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol 2001; 166(2):1141–1147.PubMedGoogle Scholar
  28. 28.
    Coler RN, Reed SG. Second-generation vaccines against leishmaniasis. Trends Parasitol 2005; 21(5):244–249.CrossRefPubMedGoogle Scholar
  29. 29.
    Cruz A, Beverley SM. Gene replacement in parasitic protozoa. Nature 1990; 348(6297):171–173.CrossRefPubMedGoogle Scholar
  30. 30.
    Titus RG, Gueiros-Filho FJ, de Freitas LA et al. Development of a safe live Leishmania vaccine line by gene replacement. Proc Natl Acad Sci USA 1995; 92(22):10267–10271.CrossRefPubMedGoogle Scholar
  31. 31.
    Zaph C, Uzonna J, Beverley SM et al. Central memory T-cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat Med 2004; 10(10):1104–1110.CrossRefPubMedGoogle Scholar
  32. 32.
    Pakpour N, Zaph C, Scott P. The central memory CD4(+) T-cell population generated during Leishmania major infection requires IL-12 to produce IFN-gamma. J Immunol 2008; 180(12):8299–8305.PubMedGoogle Scholar
  33. 33.
    Tarleton RL. Depletion of CD8+ T-cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. J Immunol 1990; 144(2):717–724.PubMedGoogle Scholar
  34. 34.
    Tarleton RL, Koller BH, Latour A et al. Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 1992; 356(6367):338–340.CrossRefPubMedGoogle Scholar
  35. 35.
    Bustamante JM, Bixby LM, Tarleton RL. Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease. Nat Med 2008; 14(5):542–550.CrossRefPubMedGoogle Scholar
  36. 36.
    Zajac AJ, Blattman JN, Murali-Krishna K et al. Viral immune evasion due to persistence of activated T-cells without effector function. J Exp Med 1998; 188(12):2205–2213.CrossRefPubMedGoogle Scholar
  37. 37.
    Wherry EJ, Barber DL, Kaech SM et al. Antigen-independent memory CD8 T-cells do not develop during chronic viral infection. Proc Natl Acad Sci USA 2004; 101(45):16004–16009.CrossRefPubMedGoogle Scholar
  38. 38.
    Bixby LM, Tarleton RL. Stable CD8+ T-cell memory during persistent Trypanosoma cruzi infection. J Immunol 2008; 181:in press.Google Scholar
  39. 39.
    Wakelin D. Acquired immunity to Trichuris muris in the albino laboratory mouse. Parasitology 1967; 57(3):515–524.CrossRefPubMedGoogle Scholar
  40. 40.
    Zaph C, Rook KA, Goldschmidt M et al. Persistence and function of central and effector memory CD4+ T-cells following infection with a gastrointestinal helminth. J Immunol 2006; 177(1):511–518.PubMedGoogle Scholar
  41. 41.
    Urban JF Jr, Katona IM, Paul WE et al. Interleukin 4 is important in protective immunity to a gastrointestinal nematode infection in mice. Proc Natl Acad Sci USA 1991; 88(13):5513–5517.CrossRefPubMedGoogle Scholar
  42. 42.
    Mohrs K, Harris DP, Lund FE et al. Systemic dissemination and persistence of Th2 and type 2 cells in response to infection with a strictly enteric nematode parasite. J Immunol 2005; 175(8):5306–5313.PubMedGoogle Scholar
  43. 43.
    Anthony RM, Rutitzky LI, Urban JF et al. Protective immune mechanisms in helminth infection. Nat Rev Immunol 2007; 7(12):975–987.CrossRefPubMedGoogle Scholar
  44. 44.
    Anthony RM, Urban JF Jr, Alem F et al. Memory T (H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat Med 2006; 12(8):955–960.CrossRefPubMedGoogle Scholar
  45. 45.
    Struik SS, Riley EM. Does malaria suffer from lack of memory? Immunol Rev 2004; 201:268-290.Google Scholar
  46. 46.
    Stephens R, Langhorne J. Priming of CD4+ T-cells and development of CD4+ T-cell memory; lessons for malaria. Parasite Immunol 2006; 28(1-2):25–30.CrossRefPubMedGoogle Scholar
  47. 47.
    Morrot A, Zavala F. Effector and memory CD8+ T-cells as seen in immunity to malaria. Immunol Rev 2004; 201:291–303.CrossRefPubMedGoogle Scholar
  48. 48.
    Sano G, Hafalla JC, Morrot A et al. Swift development of protective effector functions in naive CD8(+) T-cells against malaria liver stages. J Exp Med 2001; 194(2):173–180.CrossRefPubMedGoogle Scholar
  49. 49.
    Hafalla JC, Rai U, Bernal-Rubio D et al. Efficient development of plasmodium liver stage-specific memory CD8+ T-cells during the course of blood-stage malarial infection. J Infect Dis 2007; 196(12):1827–1835.CrossRefPubMedGoogle Scholar
  50. 50.
    Good MF, Stanisic D, Xu H et al. The immunological challenge to developing a vaccine to the blood stages of malaria parasites. Immunol Rev 2004; 201:254-267.Google Scholar
  51. 51.
    Good MF, Xu H, Wykes M et al. Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research. Annu Rev Immunol 2005; 23:69–99.CrossRefPubMedGoogle Scholar
  52. 52.
    Langhorne J, Ndungu FM, Sponaas AM et al. Immunity to malaria: more questions than answers. Nat Immunol 2008; 9(7):725–732.CrossRefPubMedGoogle Scholar
  53. 53.
    Holder AA, Guevara Patino JA, Uthaipibull C et al. Merozoite surface protein 1, immune evasion and vaccines against asexual blood stage malaria. Parassitologia 1999; 41(1–3):409–414.PubMedGoogle Scholar
  54. 54.
    Stephens R, Albano FR, Quin S et al. Malaria-specific transgenic CD4(+) s protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance. Blood 2005; 106(5):1676–1684.CrossRefPubMedGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2010

Authors and Affiliations

  1. 1.Department of Pathobiology, School of Veterinary MedicineUniversity of PennsylvaniaPhiladelphiaUSA

Personalised recommendations